Reta and fertility questions are common as retatrutide research grows. Here's what is known about ovulation, hormones, pregnancy planning and cycle changes.
There is no human evidence that retatrutide, often shortened to "reta," either improves or harms fertility. What is known comes from weight-loss biology and from other drugs in the same GLP-1 family: losing a large amount of weight can restore ovulation in some people, while rapid weight loss and hormonal shifts can temporarily disrupt menstrual cycles. Because retatrutide is still an investigational drug, anyone trying to conceive should talk with a healthcare professional before starting or continuing it.
What Is Retatrutide?
Retatrutide is an experimental triple-agonist peptide that activates three hormone receptors at once: GLP-1, GIP, and glucagon. In mid-stage trials it produced very large average weight losses, which is why interest in it has grown so quickly. Retatrutide is not FDA-approved for any use, and it is not available by prescription in the United States.
Fertility is not a primary endpoint in those trials. Researchers track cycle changes, hormone levels, and adverse events, but no study has been designed to answer whether reta increases fertility. That gap is the biggest reason answers stay vague.
Does Reta Increase Fertility?
Retatrutide has not been shown to increase fertility in humans. No published human trial reports improved ovulation, sperm quality, or pregnancy rates as a result of taking it.
What can look like a fertility boost is usually a side effect of weight loss. Obesity and insulin resistance are common drivers of irregular ovulation, and when body weight drops substantially, some women with PCOS or obesity-related anovulation begin cycling again. That effect belongs to the weight loss, not to the molecule.
The same logic applies to men. Losing fat mass often raises total and free testosterone, and lower body fat is linked to better semen parameters in some studies. Still, correlation is not proof, and nobody has demonstrated that retatrutide itself improves male fertility.
Can Reta Affect Fertility Negatively?
Rapid weight loss can temporarily stop ovulation by suppressing the hormones that trigger it. This is sometimes called hypothalamic amenorrhea, and it happens when energy intake and body fat fall faster than the reproductive system can adapt.
Other concerns worth naming:
- Lean mass loss. Aggressive fat loss without enough protein and resistance training can reduce muscle, which affects metabolic and reproductive hormones.
- Nutrient gaps. Low intake during rapid weight loss may shortchange iron, zinc, vitamin D, and B12, all nutrients tied to fertility.
- Pregnancy exposure. GLP-1 medications are generally not recommended during pregnancy, and animal data on retatrutide in pregnancy is limited.
- Unknown long-term effects. Because retatrutide is investigational, its long-term hormonal profile in men and women is not established.
Stopping Reta Before Trying to Conceive
There is no official guidance specific to retatrutide because it is not approved. For approved GLP-1 weight-loss drugs, labels typically advise stopping at least two months before a planned pregnancy, and many clinicians prefer a longer window when a drug clears slowly.
Retatrutide has a long half-life of roughly six days in early studies, which means a washout period of several weeks after the last dose. If you are actively trying to conceive, do not manage that timeline alone. Work with an obstetrician or reproductive endocrinologist who knows your history.
Reta Combined With Other Hormones and Peptides
Stacking is a common question, and it complicates the fertility picture. Someone using both reta and trt, for example, is layering a weight-loss drug on top of exogenous testosterone, which itself suppresses sperm production. Testosterone replacement can drop sperm counts dramatically, and that effect has nothing to do with retatrutide.
Combination research keeps moving forward with other molecules. Studies pairing cagri and reta aim at stronger appetite suppression, but they do not answer fertility questions. Gray-market blends marketed as reta and tesa peptide or klow and reta stack have no fertility data at all and no quality oversight.
Even side-effect chatter should be read carefully. Reports about reta and mots-c stack side effects describe fatigue, injection-site reactions, and appetite swings, not fertility outcomes. Anyone following a dosing chart copied from a forum is working without human safety data.
How Different Factors Affect Fertility on Reta
| Factor | Likely Effect on Fertility | Strength of Evidence |
|---|---|---|
| Moderate weight loss | May restore ovulation and improve hormone balance | Strong, based on general obesity and PCOS research |
| Rapid, large weight loss | Can temporarily suppress ovulation and lower reproductive hormones | Moderate |
| Retatrutide specifically | Unknown for fertility; no human fertility trials | Very low |
| Exogenous testosterone (TRT) | Suppresses sperm production in men | Strong |
| Unregulated peptide stacks | Unknown; purity and dosing are not verified | None |
What to Ask a Healthcare Professional
- Should I stop retatrutide before trying to conceive, and how many weeks ahead?
- How will we monitor my cycle or semen analysis while I lose weight?
- Are my iron, vitamin D, B12, and thyroid levels in a healthy range?
- Could another medication, including TRT, be affecting my fertility more than reta?
The Bottom Line
Retatrutide is not approved to treat infertility, and no human trial shows it improves fertility. The clearest fertility effect linked to this drug class is indirect: significant weight loss can restore regular ovulation in people whose cycles were disrupted by obesity.
Rapid weight loss, low nutrient intake, and stacked hormones can push fertility in the opposite direction. If pregnancy is part of your plan, treat reta as a variable to discuss with a clinician rather than a tool to improve your chances.
Frequently Asked Questions
Does reta increase fertility?
No human trial has shown that retatrutide increases fertility. The fertility improvements sometimes reported with this drug class are tied to weight loss itself, since losing fat can restore ovulation in people with obesity-related irregular cycles. Retatrutide should not be treated as a fertility treatment.
Can reta affect fertility negatively?
It might, indirectly. Rapid weight loss can suppress the hormones that drive ovulation and lower reproductive hormone levels, and poor nutrient intake during aggressive dieting can add to the problem. Because retatrutide is still investigational, its direct effects on fertility remain unknown.
How long should I stop reta before trying to get pregnant?
There is no official guidance for retatrutide because it is not FDA-approved. Approved GLP-1 weight-loss drugs generally advise stopping about two months before conception, and retatrutide's long half-life may call for a similar or longer washout. Ask your prescriber for a plan based on your health history.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.